Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

850.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 858.00
  • 52 Week Low: 280.00
  • Currency: UK Pounds
  • Shares Issued: 48.72m
  • Volume: 23,006
  • Market Cap: £414.10m

Ergomed reports decent first quarter

By Josh White

Date: Wednesday 10 Jun 2020

LONDON (ShareCast) - (Sharecast News) - Specialist pharmaceutical services company Ergomed said on Wednesday that it had a "good" first quarter, with "solid" overall growth in revenue.

The AIM-traded firm, which was holding its annual general meeting, told shareholders that following the outbreak of Covid-19 in March, it had been successful in transitioning to a "fully remote working" operation, with "minimal disruption", and no redundancies or furloughed staff.

Its chairman, Dr Miroslav Reljanović, said the company had made good strategic progress so far in the year, with further integration of the combined business under the pharmaceutical services model.

"The Ashfield Pharmacovigilance business, acquired in January, has been integrated in line with plans as PrimeVigilance USA, providing significant commercial benefit to the group overall.

"Cash generation remains strong, and the company is in a robust financial position."

Dr Reljanović explained that, despite the impact of Covid-19 on the general business environment, in the second quarter the firm had continued to grow its order book across the business, and maintain its revenue growth trend, while implementing cost control measures.

He said the board was confident in the performance of the business for the first half of 2020.

"In line with our usual practice, in July the company will provide an update on current trading and the outlook for the remainder of the current financial year ending 31 December.

"At this time, the company is confident that results will be in line with current market expectations for the 2020 financial year."

At 1424 BST, shares in Ergomed were up 1.72% at 442.5p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 850.00p
Change Today -2.00p
% Change -0.23 %
52 Week High 858.00
52 Week Low 280.00
Volume 23,006
Shares Issued 48.72m
Market Cap £414.10m

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.82% below the market average86.82% below the market average86.82% below the market average86.82% below the market average86.82% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Price Trend
97.26% above the market average97.26% above the market average97.26% above the market average97.26% above the market average97.26% above the market average
89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average
Income Not Available
Growth
21.73% above the market average21.73% above the market average21.73% above the market average21.73% above the market average21.73% above the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 26-Nov-2020

Time Volume / Share Price
16:35 5 @ 850.00p
16:22 2,000 @ 852.00p
16:21 2,000 @ 852.00p
16:21 2,000 @ 852.00p
16:12 296 @ 852.00p

Ergomed Key Personnel

COO Lewis Cameron

Top of Page